Literature DB >> 12224616

Treatment of an acromegalic cat with the dopamine agonist L-deprenyl.

L A Abraham1, S E Helmond, R W Mitten, J A Charles, S A Holloway.   

Abstract

Acromegaly was diagnosed in a 14-year-old domestic short hair cat presented for investigation and management of apparently insulin-resistant diabetes mellitus. Treatment with L-deprenyl and high doses of insulin was commenced. The L-deprenyl did not reduce the requirement for high doses of insulin and did not appear to reduce the clinical signs associated with the disease. The cat was euthanased one year after initial presentation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224616     DOI: 10.1111/j.1751-0813.2002.tb12469.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  2 in total

1.  Pasireotide for the Medical Management of Feline Hypersomatotropism.

Authors:  C J Scudder; R Gostelow; Y Forcada; H A Schmid; D Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2015-05-06       Impact factor: 3.333

2.  Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.

Authors:  R Gostelow; C Scudder; S Keyte; Y Forcada; R C Fowkes; H A Schmid; D B Church; S J M Niessen
Journal:  J Vet Intern Med       Date:  2017-02-01       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.